Related Experiment Video
Updated: Jul 15, 2026

Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages
Published on: June 30, 2016
Effect of granulocyte-macrophage colony-stimulating factor on leukocyte function in cirrhosis
M Garcia-González1, D Boixeda, D Herrero
1Servicio de Gastroenterologia, Hospital Ramón y Cajal, Madrid, Spain.
Insights
Cirrhotic patients exhibit impaired leukocyte function, increasing infection risk. Granulocyte-macrophage colony-stimulating factor (GM-CSF) demonstrated in vitro improvement in phagocytosis and chemotaxis for these patients.
Area of Science:
- Immunology
- Hematology
- Gastroenterology
Background:
- Cirrhosis is associated with impaired leukocyte function and high infection rates.
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances phagocytic cell activity.
- Clinical applications of GM-CSF are being investigated for immune support.
Purpose of the Study:
- To evaluate the in vitro effects of GM-CSF on leukocyte function in cirrhotic patients.
- To assess phagocytosis, phagocytic index, and chemotaxis in polymorphonuclear leukocytes.
- To compare leukocyte function in compensated and infected cirrhotic patients with healthy controls.
Main Methods:
- Polymorphonuclear leukocytes (PMNs) from 21 cirrhotic patients and 14 healthy donors were analyzed.
- Basal PMN functions were tested, followed by incubation with GM-CSF (10 ng/mL).
- Phagocytosis against Candida albicans and chemotaxis via Boyden chamber were assessed.
Main Results:
- Cirrhotic leukocytes showed significantly lower basal phagocytosis and chemotaxis compared to controls.
- GM-CSF stimulation increased phagocytosis and chemotaxis in non-infected cirrhotic patients.
- GM-CSF also improved phagocytic index, phagocytosis, and chemotaxis in cirrhotic patients with peritonitis.
Conclusions:
- Leukocyte function is defective in both compensated and infected cirrhotic patients.
- GM-CSF shows potential for in vitro enhancement of immune cell function in cirrhosis.
- Further research into GM-CSF's therapeutic role in cirrhotic patients is warranted.
Background:
Cirrhotic patients have been reported to have leukocyte impaired function as well as a high incidence of infectious diseases. Granulocyte-macrophage colony-stimulating factor (GM-CSF) increases the number and function of phagocytic cells, and clinical applications are under study. We tested in vitro effects of GM-CSF on phagocytosis, phagocytic index, and chemotaxis in polymorphonuclear leukocytes from 21 cirrhotic patients (12 with compensated cirrhosis and 9 with spontaneous bacterial peritonitis).
Methods:
Polymorphonuclear leukocyte functions were tested under basal conditions and after incubation with GM-CSF (10 ng/mL). Phagocytosis was tested against a clinical strain of Candida albicans, and chemotaxis was evaluated using a Boyden chamber. Results were compared with those obtained from 14 healthy donors.
Results:
Leukocytes from cirrhotics displayed lower basal functional activity than control cells in phagocytosis (P < 0.01) and chemotaxis (P < 0.01). After GM-CSF stimulation, the percentage of phagocytic polymorphonuclear leukocytes in noninfected patients increased from 60% +/- 2.5% to 69.9% +/- 2.42% (P < 0.01), phagocytic index from 0.79 +/- 0.07 to 1.02 +/- 0.07 (P < 0.001), and chemotaxis from 61.2 +/- 12.6 to 82.3 +/- 10.2 cells/high power field (P < 0.05). In patients with peritonitis, the phagocytic index increased from 0.87 +/- 0.08 to 1.08 +/- 0.05 (P < 0.01), phagocytosis from 57.8 +/- 3.57 to 64.7 +/- 2.34 and chemotaxis from 83.3 +/- 17.8 to 110.2 +/- 24.1.
Conclusions:
Our results indicate that a defective leukocyte function is present both in compensated and infected cirrhotic patients. An in vitro improvement was observed after GM-CSF stimulation.
More Related Videos
07:51Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
12:02Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells
Published on: November 11, 2021
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Cirrhosis II: Pathophysiology